The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial
THE BIOMARKERS CONSORTIUM LAUNCHES I-SPY 2 BREAST CANCER CLINICAL TRIAL Highly Anticipated Multi-Agent Trial Opens at Major U.S. Medical Sites Groundbreaking Public-Private Collaboration Combines Personalized Medicine and Novel Trial Design to Develop Potentially Life Saving New Breast Cancer Drugs BETHESDA, MD – March 17, 2010 – The Biomarkers Consortium, a unique public-private partnership that includes ...